After the amazing success of “The Fault in Our Stars,” the romantic drama about two teens who fall in love after meeting in a cancer support group, which made a staggering $48 million opening weekend, 20th Century Fox has announced they are fast-tracking a sequel, “The Fault in Our Stars 2: Remission,” which will be in theaters next summer. According to a spokesperson for Fox, like most of Hollywood, the studio believed teens only wanted to watch epic romances about vampires or dystopian post-apocalyptic societies, but now from the boxoffice numbers of “The Fault in Our Stars” it is clear what teens really want now are films about life-threatening diseases.

“We’re going to follow the ‘Harry Potter’ model with this franchise,” the Fox spokesperson told Hollywood & Swine. “Hazel’s cancer will be a lot like Lord Voldemort, meaning it’ll be a constant threat in upcoming sequels, but it won’t officially return until the fourth film.”

In “The Fault in Our Stars 2: Remission,” Hazel moves on from the tragic events of the previous film by attending an east coast university where once again her life is placed in danger when she contracts spinal meningitis from her college dorm. Hazel will learn to love again after she meets another kindred spirit in her spinal meningitis support group, the ruggedly handsome Jake, who will be played by Taylor Lautner.

Fox also revealed they have come up with a way to bring back the character of Gus, who succumbed to his cancer at the end of the film.

“We’re going to take page out of the playbook we used when we killed off Professor Xavier in 2006’s ‘X-Men: The Last Stand,’ ” the Fox spokesperson said. “So that’s why we added a post-credits scene in ‘The Fault in Our Stars’ that reveals Gus has actually transferred his consciousness into a comatose patient.”